December 13, 2024
National Institute on Aging (NIA)
This Notice informs that, effective as of the Release Date stated above, the National Institute on Aging (NIA) is participating in PAR-25-170, Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional).
To document NIAs participation, the following sections of PAR-25-170 were modified:
Part 1. Overview Information
Components of Participating Organizations
Currently Reads:
National Institute of Neurological Disorders and Stroke (NINDS)
National Cancer Institute (NCI)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Behavioral and Social Sciences Research (OBSSR)
Modified to Read (changes shown in bold italics):
National Institute of Neurological Disorders and Stroke (NINDS)
National Cancer Institute (NCI)
National Institute on Aging (NIA)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Behavioral and Social Sciences Research (OBSSR)
Assistance Listing Number(s)
Currently Reads:
93.853, 93.399
Modified to Read (changes shown in bold italics):
93.853, 93.399, 93.866
Part 2. Full Text of Announcement
Section VII. Agency Contacts
This section was modified to add:
Scientific/Research Contact(s)
Yuan Luo, Ph.D.
National Institute on Aging (NIA)
Phone: 301-496-9350
E-mail: [email protected]
Financial/Grants Management Contact(s)
Philip Smith
National Institute on Aging (NIA)
Phone: 301-402-3465
E-mail: [email protected]
All other aspects of the NOFO remain the same.
Please direct all inquiries to:
Yuan Luo, Ph.D.
National Institute on Aging (NIA)
Phone: 301-496-9350
E-mail: [email protected]